Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Exp Cell Res ; 395(1): 112170, 2020 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-32682783

RESUMO

Colorectal cancer is the second leading cause of cancer mortality worldwide with poor prognosis and high recurrence. Aberrant Wnt/ß-catenin signaling promotes oncogenesis by transcriptional activation of c-Myc and its downstream signals. EDAR is characterized as an important effector of canonical Wnt signaling in developing skin appendages, but the interplay between EDAR and Wnt signaling in tumorigenesis and progression remains to be elucidated. In this study, we revealed that EDAR expression is prevalently elevated in colorectal cancer tissues compared with normal tissues. Further analysis suggests there is a strict correlation between EDAR expression and colorectal cancer progression. EDAR silencing by shRNA in colorectal cancer cells showed proliferative suppression via retarding cell cycle at G1 phase. Xenograft mice transplanted with shEDAR-transduced tumor cells significantly alleviated tumor burden in comparison with control mice. Furthermore, downregulation of EDAR was accompanied by reduction of ß-catenin, c-Myc and other G1 cell cycle regulators, while ß-catenin agonist restored the expression of these proteins and overrode the proliferative block induced by EDAR knockdown. These findings indicate that EDAR functions as a component of Wnt/ß-catenin signaling pathway, and is a potential modulator in colorectal carcinogenesis.


Assuntos
Proliferação de Células/fisiologia , Neoplasias do Colo , Neoplasias Colorretais/patologia , Recidiva Local de Neoplasia/metabolismo , Receptores da Ectodisplasina/metabolismo , Animais , Carcinogênese/genética , Linhagem Celular Tumoral , Proliferação de Células/genética , Transformação Celular Neoplásica/genética , Neoplasias do Colo/genética , Neoplasias do Colo/metabolismo , Neoplasias do Colo/patologia , Neoplasias Colorretais/genética , Neoplasias Colorretais/metabolismo , Regulação Neoplásica da Expressão Gênica/genética , Humanos , Camundongos , Recidiva Local de Neoplasia/genética , Receptores da Ectodisplasina/genética , Via de Sinalização Wnt/genética
2.
Dis Model Mech ; 12(4)2019 04 25.
Artigo em Inglês | MEDLINE | ID: mdl-31028034

RESUMO

Patients with mutations in the ectodysplasin receptor signalling pathway genes - the X-linked ligand ectodysplasin-A (EDA), the receptor EDAR or the receptor adapter EDARADD - have hypohidrotic ectodermal dysplasia (HED). In addition to having impaired development of teeth, hair, eccrine sweat glands, and salivary and mammary glands, HED patients have ear, nose and throat disease. The mouse strains Tabby (EdaTa ) and downless (Edardl-J/dl-J ) have rhinitis and otitis media due to loss of submucosal glands in the upper airway. We report that prenatal correction of EDAR signalling in EdaTa mice with the agonist anti-EDAR antibody rescues the auditory-tube submucosal glands and prevents otitis media, rhinitis and nasopharyngitis. The sparse- and wavy-haired (swh) rat strain carries a mutation in the Edaradd gene and has similar cutaneous HED phenotypes to mouse models. We report that auditory-tube submucosal glands are smaller in the homozygous mutant Edaraddswh/swh than those in unaffected heterozygous Edaraddswh/+ rats, and that this predisposes them to otitis media. Furthermore, the pathogenesis of otitis media in the rat HED model differs from that in mice, as otitis media is the primary pathology, and rhinitis is a later-onset phenotype. These findings in rodent HED models imply that hypomorphic as well as null mutations in EDAR signalling pathway genes may predispose to otitis media in humans. In addition, this work suggests that the recent successful prenatal treatment of X-linked HED (XLHED) in humans may also prevent ear, nose and throat disease, and provides diagnostic criteria that distinguish HED-associated otitis media from chronic otitis media with effusion, which is common in children.


Assuntos
Orelha Média/metabolismo , Orelha Média/patologia , Displasia Ectodérmica Anidrótica Tipo 1/metabolismo , Displasia Ectodérmica Anidrótica Tipo 1/patologia , Ectodisplasinas/metabolismo , Nariz/patologia , Transdução de Sinais , Animais , Anticorpos/farmacologia , Modelos Animais de Doenças , Feminino , Hialina/metabolismo , Masculino , Camundongos , Nasofaringite/complicações , Nasofaringite/patologia , Nasofaringe/efeitos dos fármacos , Nasofaringe/patologia , Otite Média/complicações , Otite Média/patologia , Fenótipo , Ratos , Receptores da Ectodisplasina/agonistas , Receptores da Ectodisplasina/metabolismo , Rinite/complicações
3.
J Biol Chem ; 284(40): 27567-76, 2009 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-19657145

RESUMO

Mutations in the TNF family ligand EDA1 cause X-linked hypohidrotic ectodermal dysplasia (XLHED), a condition characterized by defective development of skin appendages. The EDA1 protein displays a proteolytic processing site responsible for its conversion to a soluble form, a collagen domain, and a trimeric TNF homology domain (THD) that binds the receptor EDAR. In-frame deletions in the collagen domain reduced the thermal stability of EDA1. Removal of the collagen domain decreased its activity about 100-fold, as measured with natural and engineered EDA1-responsive cell lines. The collagen domain could be functionally replaced by multimerization domains or by cross-linking antibodies, suggesting that it functions as an oligomerization unit. Surprisingly, mature soluble EDA1 containing the collagen domain was poorly active when administered in newborn, EDA-deficient (Tabby) mice. This was due to a short stretch of basic amino acids located at the N terminus of the collagen domain that confers EDA1 with proteoglycan binding ability. In contrast to wild-type EDA1, EDA1 with mutations in this basic sequence was a potent inducer of tail hair development in vivo. Thus, the collagen domain activates EDA1 by multimerization, whereas the proteoglycan-binding domain may restrict the distribution of endogeneous EDA1 in vivo.


Assuntos
Colágeno/metabolismo , Ectodisplasinas/química , Ectodisplasinas/metabolismo , Proteoglicanas de Heparan Sulfato/metabolismo , Sequência de Aminoácidos , Animais , Anticorpos/farmacologia , Morte Celular , Linhagem Celular , Reagentes de Ligações Cruzadas/farmacologia , Ectodisplasinas/deficiência , Desenvolvimento Embrionário , Regulação da Expressão Gênica , Engenharia Genética , Cabelo/crescimento & desenvolvimento , Humanos , Queratinócitos/citologia , Queratinócitos/metabolismo , Camundongos , NF-kappa B/metabolismo , Multimerização Proteica , Estrutura Quaternária de Proteína , Estrutura Terciária de Proteína , Receptores da Ectodisplasina/metabolismo , Cauda
4.
Mol Biol Evol ; 25(5): 912-28, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18304980

RESUMO

It is widely accepted that evolutionary changes in conserved developmental signaling pathways play an important role in morphological evolution. However, few in silico studies were interested in tracking such changes in a signaling pathway. The Ectodysplasin (EDA) pathway provides an opportunity to fill this gap because it is involved in vertebrate skin appendage development such as scales, teeth, hair, and feathers that take an obvious part in the adaptation of species to their environment. We benefited from the large amount of genomic data now available to explore the evolution of the upstream genes of the EDA pathway. In mammals, these genes are eda (encoding 2 ligands, EDA-A1 and EDA-A2), edar (EDA-A1 receptor), edaradd (EDA receptor [EDAR] adapter), xedar (EDA-A2 receptor), and troy (a XEDAR-related receptor). We show that the evolution of EDA pathway genes combines both strongly conserved features and evolutionary shifts. These shifts are found at different signaling levels (from the ligand to intracellular signaling) and at different taxonomic levels (class, suborder, and genera). Although conserved features likely participate to the similarities found in the early development of vertebrate skin appendages, these shifts might account for innovations and specializations. Moreover, our study demonstrates that we can now benefit from the large number of sequenced vertebrate genomes to explore the evolution of specific signaling pathways and thereby to open new perspectives for developmental biology and evolutionary developmental biology.


Assuntos
Ectodisplasinas/genética , Evolução Molecular , Tegumento Comum/fisiologia , Transdução de Sinais/genética , Vertebrados/genética , Animais , Sítios de Ligação , Cricetinae , DNA Complementar , Displasia Ectodérmica/genética , Ectodisplasinas/metabolismo , Cobaias , Humanos , Hipo-Hidrose/genética , Tegumento Comum/anatomia & histologia , Macropodidae , Mesocricetus , Camundongos , Dados de Sequência Molecular , Receptores da Ectodisplasina/metabolismo , Vertebrados/anatomia & histologia , Vertebrados/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA